Predoperatsionnaya terapiya statinamiu patsientov s ishemicheskoy bolezn'yu serdtsa

Cover Page


Cite item

Full Text

Abstract

Summary. The need for statins in patients with acute and chronic forms of coronary heart disease is now beyond
doubt. However, there is still a view that from the perspective of safety it is necessary to cancel statins before a surgery
and reinstitute them after a surgery. This review examines the feasibility and safety of preoperative statin therapy
in patients with ischemic heart diseases before planned coronary bypass surgery.

References

  1. Бокерия Л.А., Зарубина Е.Ю. Возможности прогнозирования развития послеоперационной фибрилляции предсердий у пациентов, перенесших аортокоронарное шунтирование. Грудная и сердеч.-сосуд. хирургия. 2006; 2: 21-9.
  2. Taggart DP, Browne SM, Halligan PW, Wade DT. Is cardiopulmonary bypass still the cause of cognitive dysfunction after cardiac operations? J Thorac Cardiovasc Surg 1999; 118: 414-21.
  3. Abreu JE, Reilly J, Salzano RP et al. Comparison of frequencies of atrial fibrillation after coronary artery bypass grafting with and without the use of cardiopulmonary bypass. Am J Cardiol 1999; 83 (5): 775-6.
  4. Pinon P, Kaski JC. Inflammation, atherosclerosis and cardiovascular disease risk. Rev Esp Cardiol 2006; 59 (3): 247-58.
  5. Esposito S, Tremolati E, Begliatti E et al. Evaluation of rapid bedside test for the quantitative determination of C-reactive protein. Clin Chem Lab Med 2005; 43: 438-40.
  6. Advances in cardiac surgery. Eds. R.Karp, H.Laks. St. Louis, 1995: 131-67.
  7. Patti G, Chello M, Cadura D et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the Armyda-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After cardiac surgery) study. Circulation 2006; 114: 1455-61.
  8. Сlark LL, Ikonomidis JS, Crawford FA. Preoperative statin treatment is associated with reduced postoperative mortality in patients undergoing cardiac surgery: an 8-year retrospective cohort study. J Thorac Cardiovasc Surg 2006; 131: 679-85.
  9. Pan W, Pintar T, Anton J et al. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery. Circulation 2004; 110 (Suppl. 1): II45-9.
  10. Powell BD, Bybee KA, Valeti U et al. Influence of preoperative lipidlowering therapy on postoperative outcome in patients undergoing coronary artery bypass grafting. Am J Cardiol 2007; 99: 785-9.
  11. Thielmann M, Neugauser M, Marr A et al. Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery. J Thorac Cardiovasc Surg 2007; 134: 1143-9.
  12. Ali IS, Buth KJ. Preoperative statin use and outcomes following cardiac surgery. Int J Cardiol 2005; 103: 12-8.
  13. Christenson JT. Preoperative Lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 1999; 15: 394-9.
  14. Coleman CI, Lucek DM, Hammond J, White CM. Preoperative statins and infectious complications following cardiac surgery. Curr Med Res Opin 2007; 23: 1783-90.
  15. Барбараш Л.С., Шафранская К.С., Иванов С.В. и др. Возможно- сти использования модифицированной шкалы EuroScore в прогнозирования неблагоприятных исходов коронарного шун- тирования. Патология кровообращения и кардиохирургия. 2010; 2: 52-6.
  16. Lefer AM, Campbell B, Shin YK et al. Simvastatin preserves the ischemic- reperfused myocardium in normocholesterolemic rat hearts. Circulation 1999; 100: 178-84.
  17. Dotani MI, Morise AP, Haque R et al. Association between shortterm simvastatin therapy before coronary artery bypass grafting and postoperative myocardial blood flow as assessed by positron emission tomography. Am J Cardiol 2003; 91: 1107-9.
  18. Aboyans V, Labrousse L, Lacroix P et al. Predictive factors of stroke in patient undergoing coronary bypass grafting: statins are protective. Eur J Cardiothorac Surg 2006; 30: 300-4.
  19. Tabata M, Khalpey Z, Pirundini PA et al. Renoprotective effect of preoperative statins in coronary artery bypass grafting. Am J Cardiol 2007; 100: 442-4.
  20. Liakopoulos OJ, Choi Y-H, Haldenwang PL et al. Impact of preoperative statin therapy on adverse outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30 000 patients. Eur Heart J 2008; 29: 1548-59.
  21. Marin F, Pascual DA, Roldan V et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 2006; 97: 55-60.
  22. Mariscalco G, Lorusso R, Klersy C et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 2007; 84: 1158-64.
  23. Shantsila E, Watson T, Lip GY. Atrial fibrillation post-cardiac surgery: changing perspectives. Curr Med Res Opin 2006; 22: 1437-41.
  24. Ji Q, Mei Y, Wang X et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J 2009; 73: 2244-9.
  25. Knayzer B, Abramov D, Natalia B et al. Atrial fibrillation and plasma troponin I elevation after cardiac surgery: relation to inflammation- associated parameters. J Card Surg 2007; 22: 117-23.
  26. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease. Pathogenesis, predisposition, and prevention. Circulation 1998; 97: 916-31.
  27. Holt CM, Francis SE, Newby AC et al. Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery. Ann Thorac Surg 1993; 55: 1522-8.
  28. Muluk SC, Vorp DA, Severyn DA et al. Enhancement of tissue factor expression by vein segments exposed to coronary arterial hemodynamis. J Vasc Surg 1998; 27: 521-7.
  29. Lievadot J, Murasawa S, Kureishi Y et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 2001; 108: 399-405.
  30. Тепляков А.Т., Мамчур С. Е., Вечерский Ю. Ю. Коронарное шун- тирование. Оптимизация восстановительного шунтирова- ния. Томск: Изд-во Томского ун-та 2006; 362.
  31. Werda JP, Tremoli E, Massironi P et al. Statins in coronary bypass surgery: rationale and clinical use. Ann Thorac Surg 2003; 76: 2132-40.
  32. Kangasniemi OR, Biancari F, Luukkonen J et al. Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery. Eur J Cardiothorac Surg 2006; 29: 983-5.
  33. Palmerini T, Marzocchi A, Marrozzini C et al. Preoperative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. Eur J Cardiothorac Surg 2007; 31: 685-90.
  34. Field KM. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on high-sensitivity C-reactive protein levels. Pharmacotherapy 2005; 25: 1365-77.
  35. Prasad K. C-reactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 2006; 24: 33-50.
  36. Holm T, Andreassen AK, Ueland T et al. Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients. Am J Cardiol 2001; 87: 815-8.
  37. Poldermans D, Bax JJ, Kertai MD et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003; 107: 1848-51.
  38. Heeschen C, Hamm CW, Laufs U et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002; 105: 1446-52.
  39. Furukawa Y, Taniguchi R, Ehara N, Ozasa N. Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease. Circ J 2008; 72: 1937-45.
  40. Collard C D, Body SC, Shernan SK et al. Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2006; 132: 392-400.
  41. Biccard BM, Sear JW, Foex P. Statin therapy: a potentially useful perioperative intervention in patients with cardiovascular disease. Anaesthesia 2005; 60: 1106-14.
  42. Hindler K, Shaw AD, Samuels J et al. Improved postoperative outcomes associated with preoperative statin therapy. Anesthesiology 2006; 105: 1260-72.
  43. Karthikeyan G, Bhargava B. Managing patients undergoing noncardiac surgery: need to shift emphasis from risk stratification to risk modification. Heart 2006; 92: 17-20.
  44. Schouten O, Bax JJ, Dunkelgrun M et al. Statins for the prevention of perioperative cardiovascular complications in vascular surgery. J Vasc Surg 2006; 44: 419-24.
  45. Dunkelgrun M, Schouten O, Feringa HH et al. Beneficial effects statins on perioperative cardiovascular outcome. Curr Opin Anaesthesiol 2006; 19: 418-22.
  46. Schouten O, Kertai MD, Bax JJ et al. Safety of perioperative statin use in high-risk patients undergoing major vascular surgery. Am J Cardiol 2005; 95: 658-60.
  47. Werba JP, Tremoli E, Massironi P et al. Statins in coronary bypass surgery: rationale and clinical use. Ann Thorac Surg 2003; 76: 2132-40.
  48. Ridker PM, Danielson E, Fonseca C et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-207.
  49. Ballantyne CM, Houri J, Notarbartolo A et al. Circulation 2003; 107: 2409-15.
  50. Christenson JT. Preoperative lipid-control with simvastatin reduces the risk of postoperative thrombocytosis and thrombotic complications following CABG. Eur J Cardiothorac Surg 1999; 15: 394-9.
  51. Osamah H, Mira R, Sorina S et al. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets. Br J Clin Pharmacol 1997; 44: 77-83.
  52. Broijersen A, Eriksson M, Larson PT et al. Effects of function in familial hypercholesterolemia. Eur J Clin Invest 1994; 24: 488-98.
  53. Davi G, Averna M, Novo S et al. Effect of synvinolin on platelet aggregation and thromboxane B2 synthesis in type IIa hypercholesterolemic patients. Atherosclerosis 1989; 79: 79-83.
  54. Notarbartolo A, Davi G, Averna M et al. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia. Arterioscler Thromb Vasc Biol 1995; 15: 247-51.
  55. Broijersen A, Eriksson M, Leijd B et al. No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 1997; 17: 273-8.
  56. Brull DJ, Sanders J, Rumley A et al. Statin therapy and the acute inflammatory response after coronary artery bypass grafting. Am J Cardiol 2001; 88: 431-3.
  57. Muhlestein JB, Horne BD, Bair TL et al. Usefulness of in- hospital prescription of statin agents after angiographic diagnosis of coronary artery disease by improving continued compliance and reduced mortality. Am J Cardiol 2001; 87: 257-61.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Eco-Vector

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС 77 - 64546 от 22.01.2016. 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies